The Cardiometabolic Risk Initiative

---

Modifiable Risk Factors  Non-Modifiable Risk Factors  Research & Awareness  Resources  For Media

Modifiable Risk Factors: Overweight & Obesity High Blood Glucose High Blood Pressure Abnormal Lipid Metabolism High Triglycerides Physical Inactivity Smoking

What is Cardiometabolic Risk?

Cardiometabolic health is a measure of a person's risk for diabetes and heart disease and is a good gauge of overall health. Cardiometabolic health is determined by a set of conditions known as cardiometabolic risk factors. Keeping an eye on these risk factors can help a person avoid diabetes and heart disease and live a longer, better life.

The Cardiometabolic Risk Initiative is a national effort to encourage health care providers to focus on the prevention, recognition and treatment of all risk factors for type 2 diabetes and heart disease.  Cardiometabolic risk factors are good indicators of your patients' overall risk of developing heart disease and type 2 diabetes. Cardiometabolic risk factors include:

Overweight & Obesity High blood glucose Hypertension Inflammation & hypercoagulation Abnormal Lipid Metabolism

Physical inactivity Smoking Age, race and ethnicity, gender, & family history

Each of these risk factors pose a danger to good health, and the more your patients have the greater their risk of type 2 diabetes and heart disease.

Through a variety of educational and public awareness activities, the American Diabetes Association is working to educate patients about their cardiometabolic risk factors, helping them learn more about their risk for type 2 diabetes and heart disease so they can take action to lower their risk. First things first: We're encouraging patients to talk to their Doctor, Nurse Practitioner, or Physicians Assistant about their risk.

Coming Soon

• Get free patient education materials.
• Learn more about at-risk patients.
• Learn more about the patient component of this campaign, CheckUp America.
• Get Professional Resources including patient handouts, professional tools, and more.

Related Research

Learn more about cardiometabolic risk and preventing type 2 diabetes and cardiovascular disease:

• Preventing Cardiovascular Disease and Diabetes - 2006

• The Metabolic Syndrome: Time for a Critical Appraisal- 2006

• The Metabolic Syndrome (Emperor) Wears No Clothes - 2006

---

Cardiometabolic Risk Initiative is made possible by support from:

sanofi-aventis Bristol-Myers Squibb Co. Eli Lilly and Company

GlaxoSmithKline Merck & Merck/Schering-Plough Pharmaceuticals Takeda Pharmaceuticals North America